James Hambro & Partners LLP increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 204,580 shares of the semiconductor company's stock after buying an additional 3,120 shares during the period. Synopsys comprises 3.7% of James Hambro & Partners LLP's investment portfolio, making the stock its 18th largest holding. James Hambro & Partners LLP owned approximately 0.13% of Synopsys worth $87,692,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in SNPS. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH raised its stake in shares of Synopsys by 133.8% during the first quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 49,821 shares of the semiconductor company's stock worth $21,366,000 after purchasing an additional 28,516 shares during the last quarter. Affinity Capital Advisors LLC boosted its position in Synopsys by 2.1% during the first quarter. Affinity Capital Advisors LLC now owns 3,175 shares of the semiconductor company's stock worth $1,337,000 after purchasing an additional 65 shares in the last quarter. Dynamic Advisor Solutions LLC acquired a new stake in Synopsys in the 1st quarter valued at about $1,000,000. Dohj LLC grew its position in shares of Synopsys by 165.6% in the first quarter. Dohj LLC now owns 4,236 shares of the semiconductor company's stock valued at $1,817,000 after purchasing an additional 2,641 shares during the last quarter. Finally, Opal Wealth Advisors LLC acquired a new stake in shares of Synopsys during the first quarter valued at $126,000. Institutional investors and hedge funds own 85.47% of the company's stock.
Insider Buying and Selling
In other news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the completion of the transaction, the chief executive officer now owns 71,589 shares in the company, valued at $32,782,750.77. This trade represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Shelagh Glaser sold 7,310 shares of the business's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the transaction, the chief financial officer now owns 15,291 shares of the company's stock, valued at $7,427,144.52. This trade represents a 32.34% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. KeyCorp set a $540.00 price objective on shares of Synopsys in a research note on Tuesday, June 3rd. Piper Sandler reiterated an "overweight" rating and issued a $615.00 target price (down previously from $653.00) on shares of Synopsys in a research note on Thursday, May 29th. Mizuho decreased their price target on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Bank of America cut their price target on Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a report on Wednesday, April 16th. Finally, Wells Fargo & Company lowered their price objective on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $607.14.
Read Our Latest Stock Analysis on SNPS
Synopsys Stock Up 0.1%
Shares of SNPS stock traded up $0.48 during mid-day trading on Monday, reaching $479.34. 474,216 shares of the stock traded hands, compared to its average volume of 1,155,897. The stock's fifty day simple moving average is $466.31 and its two-hundred day simple moving average is $480.91. The company has a market cap of $74.37 billion, a price-to-earnings ratio of 32.98, a price-to-earnings-growth ratio of 3.23 and a beta of 1.11. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $624.80.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.40 by $0.27. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. Synopsys had a return on equity of 20.48% and a net margin of 36.12%. The company's revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.00 earnings per share. On average, equities research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.